Catalyst Wire Dossier Catalyst Wire Dossier

SLOG regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SLOG regimen, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer [Phase 2]

See pricing